Abbreviations & Acronyms AMPA = a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid BOO = bladder outlet obstruction BPH = benign prostatic hyperplasia DO = detrusor overactivity HIF-1 = hypoxia-inducible factor-1 IL = interleukin LUTS = lower urinary tract symptoms NGF = nerve growth factor NO = nitric oxide NVC = non-voiding contraction OAB = overactive bladder pBOO = partial bladder outlet obstruction TGF-b = transforming growth factor-b Abstract: The functions of the lower urinary tract have been investigated for more than a century. Lower urinary tract symptoms, such as incomplete bladder emptying, weak urine stream, daytime urinary frequency, urgency, urge incontinence and nocturia after partial bladder outlet obstruction, is a frequent cause of benign prostatic hyperplasia in aging men. However, the pathophysiological mechanisms have not been fully elucidated. The use of animal models is absolutely imperative for understanding the pathophysiological processes involved in bladder dysfunction. Surgical induction has been used to study lower urinary tract functions of numerous animal species, such as pig, dog, rabbit, guinea pig, rat and mouse, of both sexes. Several morphological and functional modifications under partial bladder outlet obstruction have not only been observed in the bladder, but also in the central nervous system. Understanding the changes of the lower urinary tract functions induced by partial bladder outlet obstruction would also contribute to appropriate drug development for treating these pathophysiological conditions. In the present review, we discuss techniques for creating partial bladder outlet obstruction, the characteristics of several species, as well as issues of each model, and their translational value.
Introduction
pBOO resulting from BPH is a common problem in aging men, with increasing prevalence of LUTS, such as incomplete bladder emptying, weak urine stream, urinary frequency, urgency, urge incontinence and nocturia. 1 However, the pathogenesis of LUTS in patients with pBOO remains to be elucidated. OAB is a symptom-based diagnosis defined by the International Continence Society as urinary urgency with or without urge incontinence, usually with daytime frequency and nocturia. 2 Urinary urgency, defined as a sudden compelling desire to void, is a common condition with an estimated overall prevalence of 11.8% in Europe and Canada, 12.8% in women and 10.8% in men. 3 The pathophysiology of OAB can be partly explained by pBOO as a result of BPH on the bladder urothelium, detrusor muscle and neurological function. DO is a urodynamic observation characterized by involuntary contractions during the filling phase of cystometry that can be spontaneous or provoked. 4 Although the symptoms of urgency described by OAB patients often correlate with DO seen on cystometry, it must be emphasized that OAB and DO are not synonymous. Just 64% of patients diagnosed with OAB had demonstrable DO in a urodynamic study. 5 The study also showed that >30% of patients with DO did not have OAB.
The mechanisms of OAB involved are complex, and include both peripheral and central nervous system factors. Animal models of OAB can be roughly divided into peripheral and central models based on the predominant site of the deficit. Peripheral models are considered to result from direct damage to the bladder, its peripheral innervation or blood supply, whereas central models develop following injuries to the spinal cord, brainstem or higher centers, such as Parkinson's disease, 6 cerebral infarction model 7 and so on. The functional roles of the lower urinary tract have been investigated for over a century. Our understanding of lower urinary tract functions remains incomplete, as human studies and research using human material are essentially limited because of legal, ethical and moral implications. Multiple animal models are used for lower urinary tract research, and these models enable more precise characterization of the development of DO, the responses to pharmacological treatment and the molecular events involved in the bladder response to pBOO. They have provided an understanding of many aspects of the pathophysiology. No matter what type of model is used, caution should be used when extrapolating the results from studies with animals to applications with humans.
The present review focuses on the research findings from animal studies of pBOO, particularly addressing the morphological and functional mechanisms. We will first discuss some basic issues associated with the topic of experimental techniques, and what must be considered in the reproducibility of animal models. Then, we will review studies that have shown some evidence of morphological bladder changes from light microscope to electron microscope analysis and bladder function from muscle strip to cystometry. We will consider the mechanisms involved in the emergence of DO. This would not only lead to an understanding of the pathophysiology of lower urinary tract symptoms induced by pBOO, but would also contribute to appropriate drug development against the pathophysiological conditions.
Previous studies have reported that animals with pBOO showed various changes in the lower urinary tract functions. pBOO leads to several morphological and functional changes in not only the bladder, but also various nerve pathways. To overcome pBOO for bladder empting, bladder muscle hypertrophy is a reproducible consequence of BOO in animal models, and causes an increase in the thickness and weight of the bladder wall. 8 To clarify the pathophysiology of pBOO, several models have been developed using various forms of urethra obstruction. From a survey of this topic, it is evident that different animal species with surgical induction of BOO have been used to study lower urinary tract functions. This has been established in several animal species including both sexes of pig, dog, rabbit, guinea pig, rat and mouse. Although the use of each species presents advantages and disadvantages, there are several common features. In the following sections, research findings of different animal species have been categorized separately.
Pigs
Porcine pBOO bladder muscle strips showed enhanced spontaneous phasic activity, which might contribute to studying the myogenic bladder function in vivo. 9 Shaw et al. reported that in a porcine model of pBOO using a radio telemetry wireless urodynamic measurement system, voiding profiles showed a prolonged micturition time with high micturition pressure and a reduction in bladder compliance. 10 Although many devices have been relatively easily adapted to the swine model because of body size, the number of porcine model studies has recently decreased.
Dogs
pBOO bladder muscle strips show changes of responses to adrenergic receptor activity. 11 Perfusion and oxygenation in the bladder under various physiological conditions were also reported. 12 Various lower urinary tract surgeries were investigated using not only pBOO, but also lower urinary tract organs. 13 Using neonatal dogs, both the ureter and bladder deposition of collagen in the lamina propria and muscular layers were investigated. 14 Recently, dogs or pigs were mostly used in experiments with new surgical procedures, devices and tissue-engineering techniques.
Rabbits
This was deleted with the thought that all researchers worked vigorously, not just Levin et al. 15 One of the main reasons for using a rabbit model is that the contractility of the rabbit bladder is very similar to that of the human bladder based on the muscle strip study. 16 The major characteristics of the rabbit's response to pBOO is an increase in bladder weight, reduced bladder compliance and development of DO in 30%, which mimics BPH patients. 17 pBOO resulted in a decrease in the activity of choline acetyltransferase. 18 Increased muscle content is mostly driven by changes in the number, rather than in the size, of smooth muscle cells. 19 Elevations in reactive oxygen species and reactive nitrogen species, and changes in the activity of anti-oxidant mechanisms are induced by pBOO models. 20, 21 Rho-kinase inhibitors significantly suppressed the force of the spontaneous contractions. 22 
Guinea pigs
Isolated pBOO bladders of Guinea pigs have been widely used for their morphology and functional mechanisms, which show a significant association between conscious voiding and structural and contractile property changes. 23 Some studies specifically focused on the interstitial cells of Cajal. Interstitial cells of Cajal-like cells were first found in the upper urinary tract of guinea pigs by Klemm et al. 24 Several populations of interstitial cells of Cajal exist in the bladder and are associated with intramural nerves. However, it remains to be ascertained how the interstitial cells of Cajal control the lower urinary tract. In Guinea pigs, pBOO induced a reduction in micturition interval, an increase in micturition pressure, produced DO and an increase in the population of interstitial cells of Cajal, 25 a reduction in nerve density, total anti-oxidant capacity, glutathione and glutathione reductase, 26 a reduction in sensory innervation and an increase in cholinergic innervation, 27 enhanced RhoA/ Rho-kinase pathway, 28 and an increase in NO production. 29 
Rats
Rats are the most frequently used model for investigating the pathogenesis and therapy of pBOO-associated structural bladder alterations. As with other animal models, these include an increase in bladder weight, hypertrophy of the suburothelium and subserosal areas, 30 decrease in micturition interval, decrease in micturition volume, and increase in micturition pressure and non-voiding bladder contractions. 31, 32 pBOO also produced an increase in the expression of alpha 1D-adrenergic receptors, 33 M2 and M3 muscarinic receptors and P2X3 purinoceptors in the urothelium, an increase in M3 muscarinic receptors in the detrusor, 34 an increase in beta2 and 3 adrenergic receptors, 35, 36 an increase in NGF, transient receptor potential vanilloid 1 and transient receptor potential melastatin 8, [37] [38] [39] changes in the sensitivity of the detrusor to acetylcholine and substance-P, 40 and upregulation of 5-hydroxytryptamine 1A and 5-hydroxytryptamine 2A receptors in the detrusor. 41, 42 Furthermore, pBOO upregulated the Rhoassociated kinase pathway. 43 Upregulation of connexin 43 induces structural and functional alterations in gap junctional intercellular communication following pBOO. 44 pBOO also changes immune responses. The expression of inflammatory cytokines (IL-6 and IL-17) in the bladder, number of peripheral blood regulatory T cells and levels of TGF-b1 were assessed. Such changes eventually lead to fibrosis in the bladder. 45 
Mice
In mice, the pBOO model also shows both functional and structural changes. pBOO induced an increase in bladder volume and residual urine volume, threshold pressure, micturition pressure, detrusor pressure, and non-voiding bladder contraction. 46 ,47 pBOO induced hypoxia-activated profibrotic signaling and changes in gene expression, such as upregulation of the HIF-1 pathway. 48 Iguchi et al. reported that 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin inhibits the HIF pathways. 49, 50 The macrophage migration inhibitory factor, MIF, is also involved in the induction of muscle loss and fibrosis after pBOO. 51 Recently, an estrogen-induced pBOO model was introduced as a novel mice model. 52 Induction with testosterone and 17b-estradiol produced voiding dysfunction, suggesting a suitable model of pBOO for better understanding of the molecular mechanisms of BPH/pBOO. 53 The number of male mice pBOO studies have increased in the past few years. In addition to the classical obstruction model of pBOO, transgenic mice were also used. Lin et al. utilized transgenic mice expressing human cytochrome P450arom cDNA under the control of the ubiquitin C promoter in the C57Bl/6J genetic background (AROM+/6J), analysis of the regulatory pathways in pBOO. 54 Our group reported that IL-1b has the potential to induce bladder remodeling and deteriorate urodynamic parameters in pBOO, which was based on observations of a pBOO model with female wild-type C57/BL6 mice and IL-1b À/À mice. 55 However, some factors were different in bladder functions after pBOO because of species differences. For example, prostaglandin E2 receptor EP1 was not involved in controlling micturition in BOO mice 56 in contrast to the findings in rats. 57 Techniques of pBOO procedure pBOO models differ drastically from acute BOO models. Compared with human BPH, some models are potentially more acute and strict. Although the urethra is constricted by a ligature tied firmly against a calibration rod, ideally, BOO develops as gradually as possible. The purpose of this section was to introduce various pBOO procedures. The most common method of inducing pBOO is a reduction of the urethral diameter by tying a suture around the urethra using a transperitoneal approach (Table 1) . 58 Usually, with or without introduction of a urethral catheter, a 0.7-mm internal diameter, 1.1-mm external diameter rod was placed adjacent to the urethra and a ligature was placed around the urethra. However, this obstruction model is well-known because of the degree of obstruction. Some researchers reported that the mortality rate is usually ≥15%, 59,60 even when a highly standardized technical degree of obstruction is applied. 61 Our group implanted PE 200 polyethylene tubing (Clay-Adams, 1.4-mm internal diameter, 1.9-mm outside diameter) around the proximal urethra (wrapping model). We speculated that BOO using the PE 200 represents relatively mild obstruction compared with the ligation model. The degree of bladder remodeling and dysfunction caused by pBOO varies. 62 Levin et al. reported that in pBOO models, some bladders with detrusor hypertrophy function close to normal, whereas others were decompensated, showing high intravesical pressure and large residual urine volume. 63 In view of these results, they classified the pBOO model not in terms of the degree of obstruction, but in terms of bladder weight. 64 This is one way of solving the pBOO problem.
Several disadvantages of the transperitoneal animal model have been reported. The abdomen is opened through a midline incision and the tissue around the bladder is dissected, and injuries affecting bladder function can occur. The pelvic organs were dissected, and the trauma might induce nerve impairment and bladder deformity, which might influence bladder function. The healing process of the abdominal incision also occurs with inflammation and adhesion to the bladder to the abdominal wall, both aspects that further invite disturbances to bladder function and are not typically part of human BPH. In fact, the bodyweight of the sham-operated mice group increased compared with that of the intact (nonsurgical) group (unpubl. data). In addition, models using the open procedure have the potential risk of injury to partially disrupt bladder innervation, consequent denervation and neural disruption. 65 To avoid these disadvantages of the transperitoneal pBOO model, Zhang et al. reported a ligating perineal urethra model ( Fig. 1; Table 1 ). This procedure did not require a low abdominal incision, and impairment of the bladder and its innervation and periurethral blood vessel was avoided for both sexes. 66, 67 This model showed results that were similar to the transperitoneal model with regard to histological changes and cystometry data. However, Kim reported that OAB parameters changed less in the transperineal model than in the transperitoneal model, so the transperineal approach could be less effective in simulating OAB. 68 Furthermore, erectile function could be changed, because cavernous injury is inevitable during the transperineal approach procedure. In any event, only time will tell if this method is feasible and reproducible in other research.
Male and female subjects
Although both males and females were used for the model, the female model is more often chosen for its simpler anatomy. 69 However, investigators should consider that one factor influencing bladder function in response to pBOO includes sex. Streng et al. reported that the voiding patterns of male rats are somewhat different from those of females. The male pattern is more of a spike-like flow compared with that of the female, and the female pattern is interrupted for a short time when bladder pressure is increased. 70 Although these differences are generally believed to be minor in intact animals, they could be significant in transgenic animals. 71 
Morphology
Historically, the Elbadawi et al. group reported several splendid morphological studies of human bladders obtained from geriatric patients. 72 However, recently, it has become extremely difficult to obtain human specimens from legal and ethical perspectives. Previous studies suggested that morphological and functional changes in the pBOO models were different depending on the duration of pBOO, in most cases 4-6 weeks. 45 A 1-or 2-week setting has a different study (acute phase). In most studies, the chronic effects of pBOO on the bladder have been divided into two phases: compensated and decompensated. In the compensated phase, the detrusor muscle increases force to overcome the increased resistance. Despite the increasing bladder mass, the bladder contractility function is conserved. 73 In the decompensated phase, the bladder mass continues to increase, but bladder wall contractility and the emptying function deteriorate. The end of this phase is characterized by a fibrotic bladder wall, low bladder capacity and poor compliance. 16 A large number of studies focused on the compensated phase. The typical histological appearance of the wall of the pBOO bladder is bladder hypertrophy by wall thickness and a significant increase in bladder weight, which is similarly observed in patients with BPH. 74 Electron microscopic studies have shown that muscle hypertrophy and hyperplasia increased collagen deposition and a loss of parasympathetic nerve terminals, 75 which could result from unstable electrical status and might have spread disordered patterns of current. 76 These findings would support experimental observations that the hypertrophied bladder contracts with a lower threshold of stimulation, and its contractions might be weaker and less sustained than those of a normal bladder. The number of mast cells present in the mucosa/submucosa region increased in the pBOO rat bladder. 77 Several studies have shown the mechanisms of gap junctional communication in the pBOO model. 78, 79 Upregulation of connexin 43 induces structural and functional changes after pBOO, so connexin inhibitors could be a novel therapeutic option for the treatment of OAB. 44, 80 Molecular biology approach Several mediators and pathways are induced in response to pBOO: HIF-1a, IL-1b, insulin growth factor-1, TGF-b, RhoA/Rho-kinase pathway and so on. 55, 81, 82 We have previously investigated the relationship between IL-1b and morphological and functional changes after pBOO. In this study of transgenic mice, IL-1b induced bladder remodeling and worsened urodynamic parameters in pBOO. In several pBOO models, bladder blood flow was shown to be reduced. 12 Koritsiadis et al. reported a significant increase in HIF-1a expression in pBOO human bladder specimens. 83 These studies showed that pBOO induces a decrease in bladder blood flow and chronic ischemia of the bladder. The decrease in bladder blood flow (ischemia) resulting in hypoxia is followed by an increase in bladder blood flow and oxygen tension after micturition (reperfusion). Thus, chronic bladder ischemia and repeat ischemia-reperfusion during a micturition cycle might produce oxidative stress, leading to bladder denervation and the expression of tissue-damaging molecules in the bladder, such as NGF and prostaglandins. 84, 85 This might be one factor in the development of bladder dysfunction (including DO).
Cystometry
Studies of smooth muscle strips from experimental pBOO bladders have revealed many bladder properties, as previously presented. 86, 87 However, findings from such types of experiments are difficult to extrapolate to the bladder as a living organ. pBOO causes morphological changes in the bladder, as well as (urodynamic) changes in bladder function. 88 The cystometry of urodynamics is a traditional investigative approach for detecting changes in bladder function in rodents. 89 Recently, Schneider et al. developed an assessment system of lower urinary tract function that incorporates the synchronous measurement of bladder activity with external urethral sphincter function in awake rats. 90 Rats and mice are two of the primary species used for evaluating urodynamic parameters. The most widely used animals for such experiments are rats because of the relative ease of use in the technology involved compared with mice. 91 The mouse bladder is more similar to the human bladder; for example, both contain intramural ganglia. However, the approach of carrying out continuous cystometry in mice can be technically challenging because of their small bladder capacity. 91 Developments in genetic modification techniques have led to an increasing use of knockout models and other transgenic mice in establishing experimental models of LUTS. 92 Several cystometric parameters can be measured in rodent models. It is hard to determine a normal range, as several factors, such as device settings and configurations, can influence urodynamic testing. A control group consisting of ageand sex-matched healthy or sham animals must be part of every study involving cystometric analysis in order to establish a baseline for comparison of the different parameters. The following parameters were commonly investigated: voided volume, residual volume (the bladder was emptied with suction through a syringe after micturition), bladder capacity (voided volume plus residual volume), threshold pressure (bladder pressure at the start of detrusor contraction for micturition), micturition pressure (maximum voiding pressure), micturition interval and baseline pressure. 69, 93 Figure 2 shows a typical conscious filling cystometrogram. When compared with the sham rat, the voiding pattern was changed in the pBOO group. In particular, NVCs were observed during the urine storage phase in the pBOO group. Consistent with previous results, the pBOO group had a prolonged micturition interval, increased voided volume, residual volume and threshold pressure. 94, 95 Bladder capacity and voiding pressure were also increased in the pBOO group, reflecting bladder enlargement and hypertrophy. NVCs (in some instances described as pre-micturition contractions) were defined as increases in bladder pressure >2.0 to 4.0 cmH 2 O during the filling phase except for the first few minutes, which was not accompanied by micturition. 8, 96 Bladder is an unreliable witness OAB is a clinical diagnosis based on the presence of the symptom of urinary urgency. As we know, the bladder is an unreliable witness. 97 OAB is highly prevalent and overlaps with DO, which accompanies bladder contractions during urine storage. DO is the urodynamic hallmark of OAB. However, DO and OAB are not synonymous, indeed, cystometric studies determined that as many as 50-75% of men with BPH have concomitant DO. Indeed, in humans with normal lower urinary tracts, DO was observed during urodynamic studies. Urgency in animals cannot be ascertained or quantified in animals, even if voiding behavior changes. It is widely recognized that we must use surrogate markers. That is the reason why most experimental models must be used as NVCs for OAB symptoms of animals.
DO
pBOO could lead to the development of DO. What mechanisms are involved in this genesis? Are neurogenic and/or myogenic mechanisms involved? These mechanisms have not been clearly understood. 98 Two main hypotheses have been proposed to explain the pathophysiological basis of DO: (i) central nervous system; and (ii) peripheral mechanisms. The latter hypotheses focus on not just the detrusor muscle, but also on peripheral autonomy.
pBOO has a neurogenic effect on bladder muscle, and hypertrophy of bladder neurons is described in both animals and humans, which facilitates the micturition reflex. 99 In the "silent C fibers" theory, nerve fibers that are normally "silent" during the physiological voiding mechanism activate after pBOO in new neuronal pathways, which could cause irritative urinary symptoms and DO. pBOO changes both sensory and motor neurons. 100 In a rat model, there is hypertrophy of bladder afferent and efferent neurons accompanying increased reflex micturition activity. 101, 102 NGF has been found to increase in pBOO bladders, suggesting an explanation for the increases in afferent nerve activity. Several lines of evidence suggest that NGF is a mediator of pBOOinduced morphological and functional changes, which contribute to the development of DO. [103] [104] [105] Glutamatergic receptors mediated alterations in bladder afferent pathways in pBOO rats. 8 Our group reported the role of peripheral AMPA glutamatergic receptors on the pathogenesis of NVCs after pBOO. 69, 96 Chronic blockade of AMPA receptor antagonists could significantly increase bladder capacity and voided volume without changes in voiding efficiency or micturition pressure (unpubl. data). And, the effects of NO in pBOO have been studied. 106 Major sites of NO release were the urothelium and afferent nerves; 107 NO modulate in various parts of lower urinary tract functions. Previously, some authors proposed that NO might be involved in the regulation of the threshold for bladder afferent firing.
108 BOO mice treated with aminoguanidine, inhibitor of NO formation, showed fewer NVCs.
The neurogenic hypothesis proposes that DO is caused by neural plasticity within the central nervous system, which gives rise to generalized, nerve-mediated excitation of the detrusor muscle. This might result from damage to descending inhibitory pathways arising from higher brain centers, inappropriate expression of spinal bladder reflexes or as a result of the sensitization of afferent terminals. In the past few decades, various modalities of functional brain imaging have been used to analyze brain control of micturition in human subjects. 109, 110 The results suggest that the brain's reaction to the micturition reflex changed after pBOO.
The myogenic hypothesis is associated with the spontaneous contractile activity of bladder myocytes. Various studies showed muscle ultrastructural changes, which induce large contractions compared with the normal detrusor status.
111,112 pBOO might lead to increased electrical coupling between muscle cells and induced DO. 113 Both neurogenic and myogenic hypotheses could not fully account for all recognized clinical and experimental findings of OAB. Recently, bladder micromotions were reported. This is spontaneous muscle contractile activity in some parts at a time when other parts are relaxing. 114, 115 Micromotions have been shown in several normal animals, which leads to the idea that individual activity would have little effect on intravesical pressure (poor coupling) in normal status. 116 However, functional remodeling of the detrusor muscle induces miscoordination of individual muscle activity resulting in the emergence of DO in the pBOO model. 114 In overactive bladders, increased electrical connectivity might give rise to a premature sensation of urgency as well as DO.
Conclusions
Available animal pBOO models have limited translational value. Nevertheless, despite many limitations, there is no question that animal models have been critical in advancing the understanding of the pathophysiological mechanisms of lower urinary tract functions.
